APIs with DMF / COS or European Registered Drug Dossiers are suitably indicated in brackets.
[Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.]
COMMERCIAL APIs
| Saurav Chemicals Limited - API Product list | ||||
|---|---|---|---|---|
|
Product Name |
Category |
Regulatory Category |
||
|
USDMF |
CEP/EDMF |
Others |
||
|
COMMERCIAL APIs |
||||
|
Atropine Sulfate |
Mydriatic and cycloplegic |
#29605
|
CEP
|
|
|
Chlorzoxazone |
treatment of muscle spasm |
#033920 |
|
|
|
Clopidogrel Besylate (in tie up with Pharmathen) |
Antiplatelet |
|
EDMF |
|
|
Dexketoprofen Trometamol |
Analgesic |
#26959 |
EDMF |
Russia & MFDS (Korea) |
|
Dex Rabeprazole |
Proton pump inhibitor |
|
EDMF available |
|
|
Diethyl Carbamazine Citrate |
Anthelmintic |
#26954 |
|
WHO |
|
Febuxostat (in tie up with Pharmathen) |
Xanthine oxidase inhibitor |
|
EDMF available |
|
|
Homatropine Hydro Bromide |
Anticholineric medication Mydriatic and cycloplegic |
|
EDMF available |
|
|
Homatropine Methyl Bromide |
Anticholineric medication Mydriatic and cycloplegic |
#23963 |
EDMF |
ANVISA |
|
Ketorolac Tromethamine |
Analgesic |
Q1 22-23 |
EDMF |
Russia, MFDS (Korea) & ANVISA |
|
Levofloxacin Hemihydrate |
Broad Spectrum Antibiotic |
|
EDMF available |
|
|
Nitisinone |
4-hydroxyphenylpyruvate dioxygenase |
#035810 |
EDMF available |
|
|
Obidoxime Hydrochloride |
Antidote: Cholinesterase reactivator
|
Q1 21-22
|
Q4 20-21 |
|
|
Pregabalin(in tie up with Pharmathen) |
Anticonvulsant drug |
|
|
eCTD available |
|
Papaverine HCL |
Erectile Dysfunction |
Q2 21-2 |
|
|
|
Ipratropium bromide |
Bronchodilator |
Q4 21-22 |
Q4 21-22 |
|
|
Ketoprofen |
Non-steroidal anti-inflammatory drug, or NSAID |
Q3 21-22 |
Q3 21-22 |
|
APIs LAUNCHING
| Saurav Chemicals Limited - API Product list | ||||
|---|---|---|---|---|
|
Product Name |
Category |
Regulatory Category |
||
|
USDMF |
CEP/EDMF |
Others |
||
|
APIs Launching |
||||
|
Carglumic Acid
|
Treatment of hyperammonaemia
|
Q4 22-23
|
|
|
|
Clopidogrel Bisulfate Form II
|
Antiplatelet |
Q3 22-23
|
|
|
|
Tiopronin
|
Treatment of severe homozygous cystinuria
|
Q2 22-23
|
|
|
|
Vildagliptin |
Anti-hyperglycemic agent |
Q3 22-23
|
|
|
UNDER DEVELOPMENT
| Saurav Chemicals Limited - API Product list | ||||
|---|---|---|---|---|
|
Product Name |
Category |
Regulatory Category |
||
|
USDMF |
CEP/EDMF |
Others |
||
Under Development - Launch by end of 2022 |
||||
|
Dapagliflozin
|
Anti-diabetic
|
|
|
|
|
Tiotropium
|
Antimuscarinics/ Antispasmodics
|
|
|
|
|
Empagliflozin
|
Anti-diabetic
|
|
|
|
|
Ticagrelor
|
CNS/Prevention of stroke
|
|
|
|
INTERMEDIATES
| Saurav Chemicals Limited - Intermediates list | ||||
|---|---|---|---|---|
|
Product Name |
Category |
Regulatory Category |
||
|
USDMF |
CEP/EDMF |
Others |
||
Intermediates |
||||
|
5-CHLOROSALICYLAMIDE
|
|
|
|
|
|
ACETOXY ETHYL BROMIDE
|
|
|
|
|
|
BMC
|
|
|
|
|
|
BROMO BUTRYRIC ACID
|
|
|
|
|
|
CHLORO ACID |
|
|
|
|
|
DIETHYL 2-THIENYL METHYLMALONATE |
|
|
|
|
|
HYDROBROMIC ACID-48% |
|
|
|
|
|
ILC |
|
|
|
|
|
L-PROLINE BENZYL ESTER HYDROCHLORIDE |
|
|
|
|
|
MONO NITRO BENZYL MALONATE |
|
|
|
|
|
PARA BROMO BENZALDEHYDE |
|
|
|
|
|
PARA BROMO BENZYL BROMIDE |
|
|
|
|
|
PARA NITRO BENZAL DEHYDE |
|
|
|
|
|
PARA NITRO BENZOIC ACID |
|
|
|
|
|
PARA NITRO BENZYL ALCOHOL |
|
|
|
|
|
PARA NITRO BENZYL BROMIDE |
|
|
|
|
|
PARA NITRO BENZYL CHLORIDE |
|
|
|
|
|
PARA NITRO BENZYL DIAZOACETATE |
|
|
|
|
